Weiyu Zhang

Weiyu Zhang

Auto-generated profile, based on publicly available information

Weiyu Zhang

InnoHK Centre for Translational Stem Cell Biology, Hong Kong Special Administrative Region, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JYJiao Yang
Jiao Yang
JDJiameng Dan
Jiameng Dan
NZNannan Zhao
Nannan Zhao
LLLin Liu
Lin Liu
HWHuasong Wang
Huasong Wang
JLJiafu Long
Jiafu Long
Zygotic genome activation occurs in two-cell (2C) embryos, and a 2C-like state is also activated in sporadic (~1%) naïve embryonic stem cells in mice. Elevated chromatin accessibility is critical for the 2C-like state to occur, yet the underlying molecular mechanisms remain elusive. Zscan4 exhibits burst expression in 2C embryos and 2C-like cells. Here, we show that Zscan4 mediates chromatin remodeling to promote the chromatin accessibility for achieving the 2C-like state. Through coimmunoprecipitation/mass spectrometry, we identified that Zscan4 interacts with the corepressors Kap1/Trim28, Lsd1, and Hdac1, also with H3K9me3 modifiers Suv39h1/2, to transiently form a repressive chromatin complex. Then, Zscan4 mediates the degradation of these chromatin repressors by recruiting Trim25 as an E3 ligase, enabling the ubiquitination of Lsd1, Hdac1, and Suv39h1/2. Degradation of the chromatin repressors promotes the chromatin accessibility for activation of the 2C-like state. These findings reveal the molecular insights into the roles of Zscan4 in promoting full activation of the 2C-like state.

22 April 2025 in Nucleic Acids Research
Verified
Journal Article
Open access
WZWeiyu Zhang
Weiyu Zhang
HFHaifeng Fu
Haifeng Fu
YHYunying Huang
Yunying Huang
MZMing Zeng
Ming Zeng
XOXiangyu Ouyang
Xiangyu Ouyang
PLPentao Liu
Pentao Liu
N 6-methyladenosine (m6A) is the most prevalent messenger RNA modification with diverse regulatory roles in mammalian cells. While its functions are well-documented in mouse embryonic stem cells (mESCs), its role in human pluripotent stem cells (hPSCs) remains to be fully explored. METTL3 is the main enzyme responsible for m6A deposition. Here, using a METTL3 inducible knockout (iKO) system, we uncovered that, unlike in mESCs, METTL3 was indispensable for hPSC maintenance. Importantly, loss of METTL3 caused significant upregulation of pluripotency factors including naïve pluripotency genes and failure to exit pluripotency, thus impairing stem cell differentiation towards both embryonic and extraembryonic cell lineages. Mechanistically, METTL3 iKO in hPSCs promoted expression and enhancer activities of two primate-specific transposable elements (TEs), SVA_D and HERVK/LTR5_Hs. At SVA_D elements, loss of METTL3 leads to reduced H3K9me3 deposition. On the other hand, the activation of LTR5_Hs in the METTL3 iKO cells is accompanied by increased chromatin accessibility and binding pluripotency factors. The activated SVA_D and LTR5_Hs elements can act as enhancers and promote nearby naïve gene expression by directly interacting with their promoters. Together these findings reveal that METTL3-dependent m6A RNA methylation plays critical roles in suppressing TE expression and in regulating the human pluripotency network.

16 December 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
HFHaifeng Fu
Haifeng Fu
CCChunxiao Chen
Chunxiao Chen
YHYunying Huang
Yunying Huang
WZWeiyu Zhang
Weiyu Zhang
SLShilong Li
Shilong Li
PLPentao Liu
Pentao Liu
N6-methyladenosine (m6A) is the most prevalent RNA modification and plays diverse roles in mammalian cells. However, its significance in human trophoblast lineage commitment and placenta development remains poorly understood. Here we show that METTL3, the primary enzyme responsible for m6A depositions, specifically marks cytotrophoblasts in human placenta, and exhibits defective expression in cytotrophoblasts from preeclampsia patients. Through in-depth in vitro investigation, we identify critical roles of METTL3 in generating human trophoblast stem cells (hTSCs) from human expanded potential stem cells, and in maintaining hTSCs’ self-renewal and identity. In hTSCs, METTL3 loss induces pro-inflammatory responses and promotes premature senescence, leading to preeclampsia-associated transcriptomic signature. Mechanistically, METTL3-dependent m6A methylation directly regulates histone modifiers such as EP300 and EZH2 to maintain epigenetic homeostasis, as well as various transcription factors, including JUND. Targeted inhibition of EP300 in hTSCs successfully ameliorate preeclampsia signature caused by METTL3 deficiency. These findings reveal METTL3-dependent m6A methylation as a critical regulator of human trophoblast development and its potential involvement in pregnancy-related diseases.